| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059307A2 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/01/2002 | WO2002059305A1 Method of detecting ethiologic factor of bronchial asthma |
| 08/01/2002 | WO2002059303A1 Nurr1 transcription factor i-box mutants having monomeric transcriptional activation activity |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059300A2 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059278A2 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | WO2002059273A2 Particle sizer and dna sequencer |
| 08/01/2002 | WO2002059271A2 Gene expression profiles in breast tissue |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059264A2 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | WO2002059262A2 Compositions and methods for detecting proteolytic activity |
| 08/01/2002 | WO2002059259A2 Methods for discovering secreted and transmembrane proteins |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059149A2 Pro-apoptotic proteins and dna molecules encoding them |
| 08/01/2002 | WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | WO2002059142A2 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
| 08/01/2002 | WO2002059137A1 Nuclease-based method for detecting and quantitating oligonucleotides |
| 08/01/2002 | WO2002059136A2 Immunoglobulin class switch recombination |
| 08/01/2002 | WO2002058848A1 Robot-friendly pcr plates |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058719A1 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 08/01/2002 | WO2002058637A2 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 08/01/2002 | WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | WO2002058623A2 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 08/01/2002 | WO2002058546A2 Methods for screening for substances which inhibit fp prostanoid receptor |
| 08/01/2002 | WO2002058533A2 Process for determining target function and identifying drug leads |
| 08/01/2002 | WO2002058532A2 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof |
| 08/01/2002 | WO2002058450A2 Regulation of cell growth by muc1 |
| 08/01/2002 | WO2002044401A3 Process for detecting low abundance rna in intact cells |
| 08/01/2002 | WO2002042732A3 A method to measure the activation state of signaling pathways in cells |
| 08/01/2002 | WO2002039082A3 Method and system for visual identification of microorganisms |
| 08/01/2002 | WO2002036832A3 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002029089A3 Haplotypes of the htatip gene |
| 08/01/2002 | WO2002025286A3 Methods for the diagnosis of neoplastic disorders using angiogenin |
| 08/01/2002 | WO2002022681A3 Neuronally expressed protein and use thereof |
| 08/01/2002 | WO2002016617A3 Myrosinase from brevicoryne brassicae |
| 08/01/2002 | WO2002012855A3 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 08/01/2002 | WO2002010745A3 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 08/01/2002 | WO2002009573A3 Prognostic classification of endometrial cancer |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 08/01/2002 | WO2002003305A3 Method and apparatus for sequence analysis |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2002000928A3 Diagnosis of diseases associated with the immune system by determining cytosine methylation |
| 08/01/2002 | WO2001092560A3 Assay for kinases and phosphatases |
| 08/01/2002 | WO2001092551A3 Duplexed parvovirus vectors |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001077381A3 Dna analysis for determination of ancestry |
| 08/01/2002 | WO2001075113A3 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001073113A3 Monooxygenase assays |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 08/01/2002 | WO2001070955A3 Identification of essential genes in prokaryotes |
| 08/01/2002 | WO2001062967A3 A method that compares genomic sequences |
| 08/01/2002 | WO2001059161A3 Analyte assays employing universal arrays |
| 08/01/2002 | WO2001048239A3 Screening method for nucleic acids |
| 08/01/2002 | WO2001045492A3 Protein kinase stress-related proteins and methods of use in plants |
| 08/01/2002 | WO2001041815A3 Metastasis genes and uses thereof |
| 08/01/2002 | WO2001032935A9 Molecular microarrays and methods for production and use thereof |
| 08/01/2002 | WO2001029251A3 Improved mutation analysis of the nf1 gene |
| 08/01/2002 | WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 08/01/2002 | WO2001026678A9 Short segments of dap-kinase |
| 08/01/2002 | WO2001026673A9 Antibiotic-metal complex and methods |
| 08/01/2002 | WO2001025474A9 Sensor for measuring a bioanalyte such as lactate |
| 08/01/2002 | WO2001014589A3 Liquid array technology |
| 08/01/2002 | WO2001012842A9 Methods and targets of antibiotic resistance |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020104125 Nucleotide sequences coding enzymatic polypeptide for use in transforming plants and amplifying preferential oil concentration in plants |
| 08/01/2002 | US20020104117 Nucleotide sequence coding for use as tools in the generation of disease and herbicide resistant plants |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020103604 System and computer software products for comparative gene expression analysis |
| 08/01/2002 | US20020103364 Assays and probes with enzyme labels |
| 08/01/2002 | US20020103352 Decreasing adsorption of preferential particles to surfaces; obtain fluid sample, incubate with absorption mixture, monitor absortion activity of sample |
| 08/01/2002 | US20020103349 Drug-oligonucleotides chimeric molecules |
| 08/01/2002 | US20020103340 Rab proteins |
| 08/01/2002 | US20020103338 Staphylococcus aureus polynucleotides and polypeptides |
| 08/01/2002 | US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103154 Identifying genes, e.g. Saccharomyces cerevisiae, essential for germination and proliferation and using the identified genes or their encoded proteins as targets for highly specific fungicides, etc.; antifungal agents, |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |
| 08/01/2002 | US20020103128 Infecting a cell with infectious pancreatic necrosis virus |
| 08/01/2002 | US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103116 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020103082 Adjuvant activity through modulation of animal and plant cell membrane transport |
| 08/01/2002 | US20020102732 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/01/2002 | US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents |
| 08/01/2002 | US20020102722 Lac shuttle vectors |
| 08/01/2002 | US20020102721 Diagnosing cancer; obtain sample, monitor concentration tumor suppressor proteins, compare to control, amplified concentration indicate cancer |
| 08/01/2002 | US20020102718 Apparatus for use in the detection of preferential particle in biological sample |